Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation
Jazyk angličtina Země Rakousko Médium print-electronic
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
PubMed
28101650
DOI
10.1007/s00702-017-1676-0
PII: 10.1007/s00702-017-1676-0
Knihovny.cz E-zdroje
- Klíčová slova
- Acoustic analysis, DBS, Dopaminergic medication, Functional imaging, Hypokinetic dysarthria, Parkinson’s disease, rTMS,
- MeSH
- antiparkinsonika terapeutické užití MeSH
- časná diagnóza MeSH
- hluboká mozková stimulace MeSH
- lidé MeSH
- mozek diagnostické zobrazování patofyziologie MeSH
- Parkinsonova nemoc komplikace diagnóza patofyziologie terapie MeSH
- poruchy řeči diagnóza etiologie patofyziologie terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- antiparkinsonika MeSH
Hypokinetic dysarthria (HD) occurs in 90% of Parkinson's disease (PD) patients. It manifests specifically in the areas of articulation, phonation, prosody, speech fluency, and faciokinesis. We aimed to systematically review papers on HD in PD with a special focus on (1) early PD diagnosis and monitoring of the disease progression using acoustic voice and speech analysis, and (2) functional imaging studies exploring neural correlates of HD in PD, and (3) clinical studies using acoustic analysis to evaluate effects of dopaminergic medication and brain stimulation. A systematic literature search of articles written in English before March 2016 was conducted in the Web of Science, PubMed, SpringerLink, and IEEE Xplore databases using and combining specific relevant keywords. Articles were categorized into three groups: (1) articles focused on neural correlates of HD in PD using functional imaging (n = 13); (2) articles dealing with the acoustic analysis of HD in PD (n = 52); and (3) articles concerning specifically dopaminergic and brain stimulation-related effects as assessed by acoustic analysis (n = 31); the groups were then reviewed. We identified 14 combinations of speech tasks and acoustic features that can be recommended for use in describing the main features of HD in PD. While only a few acoustic parameters correlate with limb motor symptoms and can be partially relieved by dopaminergic medication, HD in PD seems to be mainly related to non-dopaminergic deficits and associated particularly with non-motor symptoms. Future studies should combine non-invasive brain stimulation with voice behavior approaches to achieve the best treatment effects by enhancing auditory-motor integration.
Zobrazit více v PubMed
J Voice. 2012 Jul;26(4):416-24 PubMed
Mov Disord. 2007 Oct 31;22(14):2043-51 PubMed
J Neurol Neurosurg Psychiatry. 2008 May;79(5):522-9 PubMed
Brain. 2012 Jun;135(Pt 6):1860-70 PubMed
J Acoust Soc Am. 2011 Jan;129(1):350-67 PubMed
Parkinsons Dis. 2014;2014:487035 PubMed
IEEE Trans Biomed Eng. 2009 Apr;56(4):1015 PubMed
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S52-5 PubMed
Comput Biol Med. 2010 Jan;40(1):54-63 PubMed
J Speech Lang Hear Res. 2010 Feb;53(1):114-25 PubMed
Front Neurol. 2014 Jan 13;4:218 PubMed
Mov Disord. 2014 Apr;29(4):532-8 PubMed
J Speech Lang Hear Res. 2010 Oct;53(5):1246-55 PubMed
Clin Linguist Phon. 2012 Oct;26(10):863-81 PubMed
Philos Trans A Math Phys Eng Sci. 2009 Jun 13;367(1896):2399-421 PubMed
J Acoust Soc Am. 1986 Nov;80(5):1329-34 PubMed
IEEE J Biomed Health Inform. 2013 Jul;17(4):828-34 PubMed
Mov Disord. 2011 Mar;26(4):728-30 PubMed
J Voice. 2011 Jul;25(4):467-72 PubMed
Brain. 2004 Mar;127(Pt 3):602-15 PubMed
Rev Neurol (Paris). 1995 Feb;151(2):105-12 PubMed
Folia Phoniatr Logop. 2010;62(3):104-9 PubMed
J Neural Transm (Vienna). 2013 Apr;120(4):597-605 PubMed
J Neurol. 2015;262(4):992-1001 PubMed
Am J Speech Lang Pathol. 2015 May;24(2):88-100 PubMed
J Acoust Soc Am. 2013 Sep;134(3):2171-81 PubMed
Lancet Neurol. 2004 Sep;3(9):547-56 PubMed
Parkinsonism Relat Disord. 2015 Jun;21(6):650-3 PubMed
J Voice. 2012 Jul;26(4):496-501 PubMed
IEEE Trans Biomed Eng. 2010 Apr;57(4):884-93 PubMed
Front Hum Neurosci. 2014 Oct 13;8:777 PubMed
IEEE Trans Biomed Eng. 2012 May;59(5):1264-71 PubMed
Mov Disord. 2005 Nov;20(11):1507-15 PubMed
BMJ Open. 2016 Nov 17;6(11):e012885 PubMed
J Acoust Soc Am. 2016 Jan;139(1):481-500 PubMed
Brain Lang. 2005 Sep;94(3):347-66 PubMed
Eur Neurol. 2003;49(4):251-3 PubMed
Comput Methods Programs Biomed. 2016 Apr;127:301-17 PubMed
Hum Brain Mapp. 2010 Feb;31(2):222-36 PubMed
J Med Syst. 2010 Aug;34(4):591-9 PubMed
Acta Neurol Scand. 2008 Jan;117(1):26-34 PubMed
Hum Brain Mapp. 2015 May;36(5):1951-62 PubMed
J Voice. 2011 Nov;25(6):751-8 PubMed
Mov Disord. 2009 Apr 15;24(5):716-22 PubMed
JAMA Neurol. 2015 Apr;72(4):432-40 PubMed
J Neurol Sci. 2008 Oct 15;273(1-2):51-6 PubMed
Am J Speech Lang Pathol. 2009 May;18(2):146-61 PubMed
Brain Lang. 2006 May;97(2):123-34 PubMed
J Commun Disord. 2000 Jan-Feb;33(1):59-88 PubMed
J R Soc Interface. 2011 Jun 6;8(59):842-55 PubMed
J Med Speech Lang Pathol. 2006;14(4):323-334 PubMed
J Neural Transm (Vienna). 2016 Apr;123(4):379-87 PubMed
Philos Trans R Soc Lond B Biol Sci. 2014 Dec 19;369(1658):20130404 PubMed
Mov Disord. 2000 Nov;15(6):1132-8 PubMed
Int J Neurosci. 2011 May;121(5):254-6 PubMed
Neurol Sci. 2014 Mar;35(3):357-63 PubMed
Parkinsons Dis. 2015;2015:382320 PubMed
Mov Disord. 2011 Mar;26(4):659-63 PubMed
J Voice. 2011 Jul;25(4):e199-205 PubMed
PLoS One. 2012;7(10):e46541 PubMed
Neuroimage. 2006 Jan 1;29(1):46-53 PubMed
J Healthc Eng. 2015;6(3):281-302 PubMed
Mov Disord. 2015 Oct;30(12):1600-11 PubMed
Mov Disord. 2012 Feb;27(2):316-9 PubMed
N Engl J Med. 2012 Oct 18;367(16):1529-38 PubMed
Neuroimage Clin. 2013 Oct 31;4:82-97 PubMed
Parkinsons Dis. 2013;2013:389195 PubMed
J Acoust Soc Am. 1989 Jun;85(6):2608-22 PubMed
Behav Neurol. 1999 Jan 1;11(3):131-7 PubMed
Mov Disord. 2015 Oct;30(12):1591-601 PubMed
Parkinsons Dis. 2011;2011:435232 PubMed
Brain Cogn. 1999 Jul;40(2):355-86 PubMed
J Speech Lang Hear Res. 2011 Apr;54(2):417-29 PubMed
Biomed Eng Online. 2007 Jun 26;6:23 PubMed
Brain Lang. 2015 Aug;147:14-20 PubMed
J Commun Disord. 2009 Mar-Apr;42(2):124-35 PubMed
Clin Neurophysiol. 2014 Nov;125(11):2150-2206 PubMed
Comput Methods Programs Biomed. 2014 Mar;113(3):904-13 PubMed
PLoS One. 2012;7(2):e32132 PubMed
Brain Lang. 2003 May;85(2):190-6 PubMed
J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):177-84 PubMed
Clin Linguist Phon. 2003 Jan-Feb;17(1):63-80 PubMed
Mov Disord. 2011 Oct;26(12):2212-9 PubMed
Parkinsonism Relat Disord. 2014 Aug;20(8):855-61 PubMed
J Neural Transm (Vienna). 2013 Feb;120(2):319-29 PubMed
J Neural Transm (Vienna). 2015 Dec;122(12):1663-72 PubMed
Parkinsonism Relat Disord. 2012 May;18(4):343-7 PubMed
J Neurophysiol. 2016 Jan 1;115(1):19-38 PubMed
J Med Speech Lang Pathol. 2014;21(3):179-186 PubMed
Mov Disord. 2011 Jan;26(1):59-64 PubMed
Comput Methods Programs Biomed. 2008 Jul;91(1):36-47 PubMed
J Neural Transm (Vienna). 2015 Aug;122(8):1135-42 PubMed
Mov Disord. 2007 Jul 30;22(10):1503-6 PubMed
J Neural Transm (Vienna). 2010 Feb;117(2):197-205 PubMed
Parkinsons Dis. 2012;2012:850596 PubMed
J Neurol Sci. 2012 Feb 15;313(1-2):7-12 PubMed
Arq Neuropsiquiatr. 2010 Oct;68(5):706-11 PubMed
J Voice. 2008 May;22(3):365-72 PubMed
Conf Proc IEEE Eng Med Biol Soc. 2010;2010:6087-90 PubMed
J Commun Disord. 2008 Nov-Dec;41(6):485-500 PubMed
Acta Neurol Scand. 2006 Feb;113(2):92-9 PubMed
Parkinsons Dis. 2011;2011:796205 PubMed
J Neurol. 2015 May;262(5):1173-81 PubMed
Sleep Med. 2016 Mar;19:141-7 PubMed
Brain. 2014 Oct;137(Pt 10):2759-72 PubMed
Neurology. 2003 Feb 11;60(3):432-40 PubMed
J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):856-64 PubMed
Comput Speech Lang. 2015 Jan;29(1):172-185 PubMed
J Commun Disord. 2010 Jan-Feb;43(1):21-34 PubMed
Eur J Neurol. 2012 Feb;19(2):340-7 PubMed
Neurology. 1998 Dec;51(6):1592-8 PubMed
J Speech Lang Hear Res. 2010 Oct;53(5):1167-77 PubMed
IEEE Trans Neural Syst Rehabil Eng. 2016 Oct 26;25(8):1319-1321 PubMed
Neurology. 2011 Jan 4;76(1):80-6 PubMed
Nat Rev Neurosci. 2007 May;8(5):393-402 PubMed
Neurology. 1998 Aug;51(2 Suppl 2):S2-9 PubMed
J Speech Hear Res. 1996 Apr;39(2):311-21 PubMed
J Commun Disord. 2010 Jan-Feb;43(1):35-44 PubMed
Neurodegener Dis Manag. 2015;5(3):233-48 PubMed
Brain Lang. 2001 Aug;78(2):233-40 PubMed
Clin Linguist Phon. 2008 Dec;22(12):957-73 PubMed
J Speech Hear Res. 1969 Jun;12(2):246-69 PubMed
J Speech Hear Res. 1969 Sep;12(3):462-96 PubMed
J Voice. 2011 Jan;25(1):76-82 PubMed
Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
Parkinson Disease Detection from Speech Articulation Neuromechanics